{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:36:41Z","timestamp":1762868201196,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["29-29","29-37"],"award-info":[{"award-number":["29-29","29-37"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.nucmedbio.2020.06.002","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T04:33:37Z","timestamp":1591331617000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents"],"prefix":"10.1016","volume":"86-87","author":[{"given":"Aya","family":"Ogata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ikenuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Ichise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10216","article-title":"Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups","volume":"6","author":"Soeda","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0010","first-page":"1608 1613","article-title":"Inhibition of LTP by beta-amyloid is prevented by activation of \u03b22 adrenoceptors and stimulation of the cAMP\/PKA signalling pathway","volume":"30","author":"Wang","year":"2009"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0015","doi-asserted-by":"crossref","first-page":"371 386","DOI":"10.1016\/j.neuropharm.2017.01.010","article-title":"Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer\u2019s disease using a biased and selective beta-1 adrenergic receptor partial agonist","volume":"116","author":"Ardestani","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0020","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1523\/JNEUROSCI.2985-10.2010","article-title":"Norepinephrine promotes microglia to uptake and degrade amyloid \u03b2 peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme","volume":"30","author":"Kong","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0025","doi-asserted-by":"crossref","first-page":"1390 1396","DOI":"10.1038\/nm1485","article-title":"Activation of \u03b22-adrenergic receptor stimulates \u03b3-secretase activity and accelerates amyloid plaque formation","volume":"12","author":"Ni","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0030","doi-asserted-by":"crossref","first-page":"458 472","DOI":"10.1111\/j.1476-5381.1972.tb08143.x","article-title":"Metabolism of isoprenaline in dog and man","volume":"46","author":"Conolly","year":"1972","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0035","doi-asserted-by":"crossref","first-page":"233 238","DOI":"10.1038\/clpt.1986.168","article-title":"Plasma catecholamine and hemodynamic responses during isoproterenol infusions in humans","volume":"40","author":"Goldstein","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0040","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.bmcl.2019.07.005","article-title":"Synthesis of (R,S)-isoproterenol, an inhibitor of tau aggregation, as an 11C-labeled PET tracer via reductive alkylation of (R,S)-norepinephrine with [2-11C]acetone","volume":"29","author":"Ikenuma","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0045","doi-asserted-by":"crossref","first-page":"854 863","DOI":"10.1097\/00004647-199609000-00010","article-title":"Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis","volume":"16","author":"Ishikawa","year":"1996","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0050","doi-asserted-by":"crossref","first-page":"569 574","DOI":"10.1111\/j.1476-5381.1992.tb09020.x","article-title":"Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat","volume":"105","author":"M\u00e4nnist\u00f6","year":"1992","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0055","doi-asserted-by":"crossref","first-page":"1533 1539","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2116\/bunsekikagaku.35.3_288","article-title":"Highly sensitive determination of isoproterenol in plasma and urine by high performance liquid chromatography with fluorescence detection","volume":"35","author":"Nohta","year":"1986","journal-title":"Bunseki Kagaku"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0065","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/jps.2600570710","article-title":"Absorption and elimination profile of isoproterenol III. The metabolic fate of dl-isoproterenol-7-3H in the dog","volume":"57","author":"Conway","year":"1968","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10611860310001648248","article-title":"Classification analysis of P-glycoprotein substrate specificity","volume":"11","author":"Didziapetris","year":"2008","journal-title":"J Drug Target"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0075","first-page":"1902 1912","article-title":"Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT","volume":"40","author":"Ichise","year":"1999","journal-title":"J Nucl Medicine"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0080","doi-asserted-by":"crossref","first-page":"1359 1365","DOI":"10.2967\/jnumed.115.160127","article-title":"PET quantification of tau pathology in human brain with 11C-PBB3","volume":"56","author":"Kimura","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0085","first-page":"328","article-title":"Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin","volume":"20","author":"Phelps","year":"1979","journal-title":"J Nucl Medicine Official Publ Soc Nucl Medicine"},{"key":"10.1016\/j.nucmedbio.2020.06.002_bb0090","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0006-2952(64)90112-1","article-title":"The fate of 3H-iso-proterenol in the rat","volume":"13","author":"Hertting","year":"1964","journal-title":"Biochem Pharmacol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980512030055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980512030055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:29:07Z","timestamp":1760848147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096980512030055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":18,"alternative-id":["S096980512030055X"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.06.002","relation":{},"ISSN":["0969-8051"],"issn-type":[{"type":"print","value":"0969-8051"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}